Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsKerin Adelson, MD
Associate Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Associate Professor Adjunct
Biography
Dr. Adelson is an Adjunct Associate Professor and was previously Chief Quality Officer for Yale Cancer Center and Smilow Cancer Hospital. Dr. Adelson graduated from Yale University School of Medicine, completed residency at Mount Sinai Medical Center and Fellowship in oncology at Columbia Presbyterian. In her Quality role, Dr. Adelson focused on improving care coordination for all patients treated in the Smilow network, aligning care with national quality metrics, and developing models to enhance patient involvement in decisions about their cancer-care. Dr. Adelson sits on several national committees including the Southwest Oncology group Cancer Delivery Committee, the National Cancer Care Network Policy Committee and the American Society of Clinical Oncology Health Information Technology Committee.
Last Updated on March 17, 2023.
Appointments
Medical Oncology and Hematology
Associate Professor AdjunctPrimary
Other Departments & Organizations
- Internal Medicine
- Medical Oncology and Hematology
- Pusztai Lab
- Yale Cancer Center
Education & Training
- Fellowship
- Columbia University College of Physicians and Surgeons (2007)
- Residency
- Mount Sinai School of Medicine (2003)
- Internship
- Mount Sinai School of Medicine (2001)
- MD
- Yale School of Medicine (2000)
Research
Copy Link
Overview
Dr. Adelson is actively involved in breast cancer clinical research and serves as an investigator on multiple clinical trials.
Medical Research Interests
Breast
ORCID
0009-0004-4507-4502
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kerin Adelson's published research.
Publications Timeline
A big-picture view of Kerin Adelson's research output by year.
Lajos Pusztai, MD, DPhil
Andrea Silber, MD
Maureen Canavan, PhD, MPH
Sarah Elizabeth Schellhorn, MD
Kim Blenman, PhD, MS
Neal Fischbach, MD
63Publications
2,250Citations
Publications
2025
Prediction of 48-h Intensive Care Unit Mortality in Hospitalized Cancer Patients: Performance of the EPIC Deterioration Index and Sequential Organ Failure Assessment Score
Leung C, Cheng L, Walton N, Nortje N, Adelson K, Hui D. Prediction of 48-h Intensive Care Unit Mortality in Hospitalized Cancer Patients: Performance of the EPIC Deterioration Index and Sequential Organ Failure Assessment Score. Journal Of Intensive Care Medicine 2025 DOI: 10.1177/08850666251386399.Peer-Reviewed Original ResearchAltmetricConceptsSequential Organ Failure AssessmentSequential Organ Failure Assessment scoreNegative predictive valueIntensive care unit mortalityPositive predictive valueIntensive care unitArea under the receiver operating characteristic curveOptimal cut-off thresholdIntensive care unit transferHospitalized cancer patientsICU mortalityCancer patientsCut-off thresholdsOrgan Failure Assessment scorePredictive valueHigh negative predictive valueICU transferLow positive predictive valueOrgan Failure AssessmentMultivariate logistic regression modelReceiver operating characteristic curveEpic Deterioration IndexOperating characteristics curvePrognostic scoreLogistic regression modelsAssociation Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality
Canavan M, Cheng L, Xiang J, Lin J, Hui D, Zhao H, Nortje N, Ratan R, Cherny N, Pham T, Giordano S, Niu J, Adelson K. Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality. Journal Of Clinical Oncology 2025, 43: 3391-3402. PMID: 41004691, DOI: 10.1200/jco-25-00530.Peer-Reviewed Original ResearchThis study investigates the impact of systemic anticancer therapy near the end of life on healthcare and hospice for older adults, showing increased acute care utilization and decreased hospice use, highlighting the need for improved end-of-life care guidelines.Oncology Medical Homes: ASCO-Community Oncology Alliance Standards.
Woofter K, Kennedy E, Adelson K, Bowman R, Chapman A, Dixit N, Gerber R, Jefferies P, Martin E, Mulvey T, Olsen M, O'Mahony D, Polite B, Sadeghi N, Shaw M, Skelton M, Cox J. Oncology Medical Homes: ASCO-Community Oncology Alliance Standards. JCO Oncology Practice 2025, 22: 365-374. PMID: 40690728, DOI: 10.1200/op-25-00498.Peer-Reviewed Original ResearchAltmetricConceptsSurvivorship care plansCare deliveryMultidisciplinary teamEnd-of-life care discussionsClinical pathwayGeriatric assessmentSystems of care deliveryQuality improvementTeam-based careOncology care deliveryModels of careGoals of careEvidence-based careContinuous quality improvementEnd-of-lifeMeasures of outcomeEvidence-based medicineCare discussionsCare planningPatient engagementHealth careIntegrative reviewMultidisciplinary team managementConsensus processExpert panelProposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences.
Huey R, Pritchett J, Vokinger K, Swenson W, Haddad T, Adelson K. Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences. American Society Of Clinical Oncology Educational Book 2025, 45: e473822. PMID: 40526882, DOI: 10.1200/edbk-25-473822.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer care deliveryCancer care costsSite of careRemote patient monitoringCare deliveryCancer careCost-containment strategiesUnited StatesTelehealth servicesCare costsVulnerable populationsPayment barriersPayment parityFacility feesCareStandard of careIncremental costHospitalHealthReimbursementPolicy changesPatient monitoringCancer treatmentUnintended consequencesComparator countriesData Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and Safety
Merriman K, Yu E, Hawkins-Daarud A, Adelson K, Shaw K, Shoenthal D, Patel J, Baganz J, Futreal A, Jaffray D, Rivera J, Chung C. Data Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and Safety. JCO Clinical Cancer Informatics 2025, 9: e2400273. PMID: 40305760, PMCID: PMC12058365, DOI: 10.1200/cci-24-00273.Peer-Reviewed Original ResearchCitationsThe association between clinical trial participation, drug costs, and performance in the Oncology Care Model
Canavan M, Westvold S, Csik V, Franks J, Rocque G, Gross C, Adelson K. The association between clinical trial participation, drug costs, and performance in the Oncology Care Model. Journal Of The National Cancer Institute 2025, 117: 1503-1505. PMID: 39842859, DOI: 10.1093/jnci/djaf008.Peer-Reviewed Original ResearchThis study investigates how clinical trial participation in the Oncology Care Model affects drug costs and performance, showing potential advantages for academic centers in value-based programs.A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?
Cherny N, Nortjé N, Kelly R, Zimmermann C, Jordan K, Kreye G, Le N, Adelson K. A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed? ESMO Open 2025, 10: 104099. PMID: 39765188, PMCID: PMC11758828, DOI: 10.1016/j.esmoop.2024.104099.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricMeSH Keywords and ConceptsConceptsEnd of lifePatients' family membersEnd of life carePalliative care servicesClinician-patient communicationHealth care resourcesHealth care costsOncology nursesMoral distressCare servicesCare resourcesCare costsTreatment teamStrained health care resourcesFamily membersProfessional societiesCancer patientsCognitive factorsOncologistsPublic educationOvertreatmentNursesPatientsCareHealth
2024
A Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non–Small Cell Lung Cancer Care
Hakim H, Alexander C, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver B. A Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non–Small Cell Lung Cancer Care. The Permanente Journal 2024, 28: 212-222. PMID: 39269215, PMCID: PMC11404665, DOI: 10.7812/tpp/23.152.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsShared decision-makingOncology cliniciansSDM principlesPerceptions of shared decision-makingImprove health care outcomesPatient-centred care modelComprehensive cancer care centerLeadership buy-inPatient-centered careHealth care outcomesLung cancer careParticipants perceived benefitsHealth care environmentTeam member rolesNon-small cell lung cancer careThematic analysis of interview dataCancer care centerSimulation-based programAnalysis of interview dataCare modelCare outcomesCancer carePatient-centeredPatient experienceCare environmentBuilding Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non–Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program
Alexander C, Hakim H, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver B. Building Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non–Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program. The Permanente Journal 2024, 28: 200-211. PMID: 39269220, PMCID: PMC11404653, DOI: 10.7812/tpp/23.160.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsShared decision-makingPractice settingsImplementation of shared decision-makingSDM trainingTraining programSimulation training programMultidisciplinary cliniciansCentered carePatient goalsPost-trainingClinician experienceFocus groupsClinical careSelf-EfficacyParticipants' understandingClinician awarenessPostinterventionPilot studyActive participationParticipantsProgram designCareCliniciansBody of evidenceGrowing body of evidenceSystemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors
Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology 2024, 10: 887-895. PMID: 38753341, PMCID: PMC11099840, DOI: 10.1001/jamaoncol.2024.1129.Peer-Reviewed Original ResearchCitationsAltmetricConceptsNational Quality ForumQuintile 5Quintile 1Improve end-of-life careEnd-of-life careCohort studyNationwide population-based cohort studyPopulation-based cohort studyEnd of lifeElectronic health record databaseHealth care practicesColorectal cancerPopulation of patientsCox proportional hazards modelsAmerican Society of Clinical OncologyQuality ForumCare practicesOverall survivalPayment incentivesProportional hazards modelHighest quintileMultivariate Cox proportional hazards modelQuintileFlatiron HealthHazard ratio
News
Copy Link
News
- January 08, 2026Source: JCO Podcast
Podcast: Association Between EOL SACT and Healthcare Utilization
- October 22, 2025Source: Cure
Improving End-of-Life Care: Making Hospice and Home Support Accessible
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO
- March 11, 2024
Oncology Hospitalists Improve Hospice Transitions for Patients with Advanced Cancers
Get In Touch
Copy Link